Skip to main content
. 2022 Nov 29;13:1019451. doi: 10.3389/fphar.2022.1019451

FIGURE 5.

FIGURE 5

FYN reduced SRSF1, GSK3β, and β-catenin protein levels. (A) Correlations between overall survival in LUAD patients and GSK3β and SRSF1 expression, analyzed using the GEPIA website. (B) HCC827OR cells were treated with FYN at IC50 or isovolumetric 1640 medium for 48 h for analysis. Protein levels of SRSF1, GSK3B, and β-catenin were determined by western blotting. Con, control; FYN, Feiyanning Formula.